FDA Investigator Michael Levin
Michael Levin has conducted inspections on 8 sites in 2 countries as of 22 Apr 2002. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
8
Last Inspection Date:
22 Apr 2002
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Spain
FDA Investigators that have inspected at least one site in common with Michael Levin:
Alice S Tsao,
Ann L Demarco,
Ann M Stewart,
Aziz A Mamur,
Benton M Ketron,
Bijoy Panicker,
Brandy N Lepage,
Candace Y Gomez Broughton,
Charanjeet Jassal,
Charisse K Green,
David R Delucia,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Dennis E Guilfoyle, PhD,
Donald G Gordon,
Donald L Lech,
Dr. Robert C Horan, MD,
Evan Tong,
Felix Maldonado,
Gary J Lehr,
Gary T Greco,
Gregson A Joseph,
Guerlain Ulysse,
Helen B Ricalde,
Iram R Hassan, PhD,
Irina Gaberman,
James A Liubicich,
Janet A Rajan,
Jay T Wong,
John A Podsadowski,
Jose Acruz Gonzalez,
Jose Ohernandez Guzman,
Jose R Hernandez,
Joy P Matthias,
Karen L Kosar,
Kellie Leveille,
Kenneth H Williams,
Kevin A Gonzalez,
Kwong P Lee,
Lawrence W Farina,
Linda M Sacco,
Manhar R Patel,
Margaret E Sarles,
Matthew A Spataro,
Michael A Charles,
Michael R Dominick,
Michele L Obert,
Mindy M Chou,
Mra Mcculloughj,
Nancy A Saxenian Emmons,
Nicholas C Mendiola,
Omadevi Somai, Investigator,
Parul M Patel,
Patricia F Hughes, PhD,
Paul Mouris,
Perry T Nichols,
Philip F Istafanos, DMV, MS,
Pratik S Upadhyay, DDC,
Rashmi Rawat, PhD,
Robert C Steyert,
Rochelle K Kimmel,
Russ E Davis,
Samuel T Walker,
Sandra D Thompson,
Shari L Kahn,
Simone E Pitts,
Sony Mathews,
Srinivas R Chennamaneni, PhD,
Steven M Weinman,
Susan M Jackson,
Susan W Ting,
Syeda N Mahazabin,
Tara K Carmody,
Torrance J Slayton,
Uduak M Inokon,
Vanessa M Williams,
William M Rennells,
Xiaoping Guan
Michael Levin's Documents
Publish Date | Document Type | Title |
---|---|---|
December, 2000 | FDA 483 | Bristol-Myers Squibb Co., Inc. - Form 483, 2000-12-15 |
April, 2001 | FDA 483 Response | Strides Pharma, Inc - Form 483R, 2001-04-30 |
February, 2001 | FDA 483 | Bristol-Myers Squibb Co., Inc. - Form 483, 2001-02-01 |
April, 2001 | FDA 483 | Strides Pharma, Inc - Form 483, 2001-04-10 |
February, 2002 | FDA 483 Response | Epic Pharma, LLC - Form 483R, 2002-03-07 |
February, 2002 | FDA 483 | COMERCIO DE PRIMERAS MATERIAS SLU. - Form 483, 2002-02-21 |
April, 2001 | EIR | Strides Pharma, Inc - EIR, 2001-04-10 |
October, 2001 | EIR | Perrigo New York, Inc. - EIR, 2001-10-26 |
January, 2000 | EIR | Jerome Stevens Pharmaceuticals, Inc. - EIR, 2000-01-27 |
February, 2001 | EIR | Bristol-Myers Squibb Co., Inc. - EIR, 2001-02-01 |
January, 2000 | FDA 483 | Jerome Stevens Pharmaceuticals, Inc. - Form 483, 2000-01-27 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more